FDA to Continue Study on Promising MS Drug - KCBD NewsChannel 11 Lubbock


FDA to Continue Study on Promising MS Drug

Last year, a promising drug to treat M.S., called Tysabri was taken off the market after concern that it may cause a rare, but potentially fatal disorder.  Now, after further studies, the FDA says it is going to allow those early studies to continue after all, because they can find no new cases of a fatal disorder.

And Tysabri was proving to slow the progresssion of the disease, and significantly cut the rate of relapse.  So, in the treatment of M.S., we'll be hearing more about Tysabri, a drug under study again.


Powered by WorldNow

5600 Avenue A
Lubbock, TX. 79404

FCC Public File
EEO Report
Closed Captioning

All content © Copyright 2000 - 2014 Worldnow and KCBD. All Rights Reserved.
For more information on this site, please read our Privacy Policy and Terms of Service.